events
News and Community
Content by Category
Artificial Intelligence in Health Tech
Medical Cloud Computing
Patient Engagement
EHR/EMR
Telehealth
Our Network
IT Tech News
CXO Insiders
Rev Tech News
Fin Tech News
HR Tech News
Client Papers
Soc News
Martech-News
events
News and Community
Content by Category
Artificial Intelligence in Health Tech
Medical Cloud Computing
Patient Engagement
EHR/EMR
Telehealth
Our Network
IT Tech News
CXO Insiders
Rev Tech News
Fin Tech News
HR Tech News
Client Papers
Soc News
Martech-News
Search
Login
events
News and Community
Content by Category
Artificial Intelligence in Health Tech
Medical Cloud Computing
Patient Engagement
EHR/EMR
Telehealth
Our Network
IT Tech News
CXO Insiders
Rev Tech News
Fin Tech News
HR Tech News
Client Papers
Soc News
Martech-News
events
News and Community
Content by Category
Artificial Intelligence in Health Tech
Medical Cloud Computing
Patient Engagement
EHR/EMR
Telehealth
Our Network
IT Tech News
CXO Insiders
Rev Tech News
Fin Tech News
HR Tech News
Client Papers
Soc News
Martech-News
Login
News and Community
Aurion Biotech
,
Aurn001
,
Cell Therapy
,
Clinical Trial
,
Corneal Edema
,
Corneal Endothelial Dysfunction
,
Corneal Treatment
,
Fuchs Dystrophy
,
Healthcare Technology
,
Phase 3 Study
,
Vision Restoration
September 24, 2026
Aurion Biotech Completes Enrollment in Pivotal ASTRA Phase 3 Study, Advancing AURN001 for Corneal Edema Treatment
Biotechnology Innovation
,
Cell Therapy
,
Healthcare Technology
,
Immune-mediated Diseases
,
Pharmaceutical Collaboration
,
Precision Medicine
,
Rna Therapeutics
,
Targeted Nanoparticles
,
Vivo Car-t
July 30, 2026
Sail Biomedicines Reveals Strategic Collaboration to Develop New Class of Medicines for In Vivo CAR-T
Load More
